Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04333771
What this trial is testing

Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Jiangsu HengRui Medicine Co., Ltd. 566
Large-scale testing (Phase 3)Study completedNCT02222493
What this trial is testing

PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Who this might be right for
Rheumatoid Arthritis
Pfizer 650
Testing effectiveness (Phase 2)Ended earlyNCT01390545
What this trial is testing

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Takeda 300
Not applicableLooking for participantsNCT06712628
What this trial is testing

A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
AbbVie 678
Large-scale testing (Phase 3)Study completedNCT01711359
What this trial is testing

A Study in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 588
Large-scale testing (Phase 3)Study completedNCT05814627
What this trial is testing

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 487
Not applicableStudy completedNCT01672970
What this trial is testing

A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 291
Large-scale testing (Phase 3)Looking for participantsNCT06596772
What this trial is testing

Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
mAbxience Research S.L. 458
Not applicableStudy completedNCT01558089
What this trial is testing

Good EULAR Response In Patients With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Pfizer 76
Not applicableStudy completedNCT04541810
What this trial is testing

Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more
AbbVie 2,369
Large-scale testing (Phase 3)Study completedNCT05842213
What this trial is testing

Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX

Who this might be right for
Rheumatoid Arthritis
Alvotech Swiss AG 502
Testing effectiveness (Phase 2)Ended earlyNCT02720120
What this trial is testing

Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 175
Post-approval studies (Phase 4)Study completedNCT00996203
What this trial is testing

Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 201
Testing effectiveness (Phase 2)Ended earlyNCT02843659
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
Bristol-Myers Squibb 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT07148414
What this trial is testing

SPY072 in Rheumatic Disease

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+5 more
Spyre Therapeutics, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT04577781
What this trial is testing

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 28
Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96
Not applicableLooking for participantsNCT07017686
What this trial is testing

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
The Bionics Institute of Australia 5
Post-approval studies (Phase 4)Study completedNCT01578850
What this trial is testing

Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

Who this might be right for
Rheumatoid Arthritis
Pfizer 491
Testing effectiveness (Phase 2)Study completedNCT02518620
What this trial is testing

An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Ablynx, a Sanofi company 406
Next Page